• No results found

Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys.

N/A
N/A
Protected

Academic year: 2021

Share "Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

ZEEVI ET AL

to tissue

bserved a

BAL cclls

lirment of

ent of this

to be due

;rstanding

BALceils

and

infec-af various

ammatory

ift.

•Λ al Heart nsplant Proc um Immunol Ann Thorac

'r'^ßjA

Products of HLA Class I and Class II (B,C,DP,DQ,DR)

Genes All Contribute to Induction of Recipient Anti-Donor

Responses in Rejected Kidneys

M. Bonneville, J F. Moreau, E. Blokland, J. Pool, D. Charron, E. Goulmy, and J.P. Soulillou

T

LYMPHOCYTES play a major role in

the development of cellular responses

leading to rejection of an allograft. We

previ-ously described a limiting dilution technique

allowing the cloning and expansion of about

10% of mechanically harvested kidney graft

invading Τ lymphocytes. Fifty-five

alloreac-Uve Τ cell clones (ATLCs), studied

phenoty-pically and functionally, were shown to react

specifically with kidney donor-derived Β

iym-phoblastoid cell line (BLCL).

1

In the present

study, we have analyzed the recognition

reper-toire of 20 of 55 ATLCs.

MATERIALS AND METHODS

The clinical Status of the recipient has already bcen described elsewhere ' Mononuclear cells infiltrating the

irreversibly rejected kidney allograft were cloned by limiting dilution and cultured with irradiated donor BLCL in RPMI 1640 supplemented with human serum and recombinant IL 2 (0 94 η moI/L) as previously described ' We tested the cytotoxic and proliferative activities of ATLCs against a set of allogeneic cells (charactenstics given in Table 1) Cytotoxicity was assessed by a Standard 5 lCr release assay1 and

prolifcra-tion by 3H-thymidine uptake after a three-day culture

with irradiated stimulator cells Positive and negative

From Inserm U211, Nantes, France, the Department of Immunohaematology, Umversity Hospital, Leiden, The Netherlands, and l'Institut des Cordehers, Paris

Addreis repnnt requests to Μ Bonneville, Inserm U2II.1 rue G Ved, 44035 Nantes, France

© 1988 by Grüne & St rat ton, Ine

0041-1345/88/2002-0014$03 00/0

Table 1. HLA Phenotype of Male and Female Panel Cells Used in Cytotoxic and Proliferative Assays

No 1 2 2' 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 2 0 2 1 Sex Μ F F Μ F Μ F Μ F Μ F Μ F Μ F Μ F Μ F F Μ Μ Origin PBL PBL PBL PBL PBL PBL PBL PBL PBL PBL PBL PBL PBL BLCL BLCL BLCL BLCL BLCL BLCL BLCL BLCL BLCL Α 2 2, 3 2 3, 11 1, 11 3, 29 1, 30 24 31 1 24 1 1, 32 3, 33 3, 32 25 25 1 3 24, 26 2 4 2 3 2 3 2, 11 28, 30 Β 4 4 35, 57 51 8, 35 62, 37 18, 44 8, 18 41, 55 49, 55 8 60 57, 60 7, 14 7 12 18 18 1 13 56, 58 7 7 7, 51 18, 55 13 55 C 5 4 2 4 7 2, 4 5, 7 3 3 7 3 7 3. 6 — — 6, 7 1 7 7 7 3 7 6, 7 HLA DR 4 1, 7 2, 7 3, 6 4 6, 9 3 6, 7 6, ί ί 2, 7 2, 7 2, 3 2 7 77 7, 8 1, 8 2 2 2, 14 8, 7 7 6, 7 DQ w3 w 1 . w/1, w/1. w3 w 1 , w/2, w 1 , w 1 , w 1 . w 1 , w 1 , w/1, w 3 , tv3, w 2 . w 1 , w 1 w 1 w 1 , w3 w 1 , w 3 w 2 w 2 w 3 w 3 M/3 w3 w3 w/2 w 2 w 2 DP — — — — — w4, w5 — — — — — w 2 w 2 — — — — — — — LBQ — — — — — — — — _ — — — 1 1 — — — — — — NOTE BLCLs No 19 and No 20 were denved frorn kidney recipient (autologous) and donor Β iymphocytes respectively Italic type denotes compatibiiity with donor's antigens

(2)

BONNEVILLE ET AL ' - S S rcactions wcrc dcfined by means of the cluster analysis

program ofCjroU et al 2 Monodondl anübodies (MoAbs) usod m olocking expenmcnls arc indicatcd in Table 2 The blocking effect of MoAbs (Wilcoxon statistical irta! ysis> Ρ < 05) was studicd at oplima! MoAb conccntra tions ind an effcclor lo targtt ratio of 20 1

RESULTS AND COMMENTS Twcnty ATLCs were tested for prohfera Hon against a panei of irradiaied ΡΗΛ blasts and Bl Cl s In addilton 15 ATI Cs (prcvi ously shown lo lyse donor BLCl ) wcrc siud icd for their lytic activity againsi a panci of s lCr I ibcllcd panc! cclls Prohfcration and cylo'oxic assays wcrc concordant and vanous rccogmtion patterns werc obscrved ( fable 2) In gcneral no prccise characten/ation of iht HI Α specjficily recogni7ed couid bc donc as largcts gcncrally sharcd scvcral Hl Α anti

gens wilh donor cclls Thercforc wc carned out biocking cxpenments LSing MoAbs dircctcd against Η LA class I and II molc culcs Cytotoxicity of threc clones (40 2 6 21 7 and IB4) was abrogatcd by addition of anti-HLA class I MoAb dunng CML assay indicating that 40 2 6 recogni7ed a Hl Α Bw55 specificity Clone 1 B4 rcactcd with cclls No 1 3 a n d N o 14 shanng BI8 and DRwI 1 with donor BLCL and probably rccognizcd thc Β18 specificity ATLC 2F7 rccogni7cd an Η LA class I spccificily sharcd bclwccn cclls 3,5689,1620 and 21 Six of eight reactive target cclls wcrc Cw7 positive whercas on thc other two reactive cclls a C blank could not be exeluded On the other hand four of 13 non reactive cclls were Cw7 -i and all of thf m wcrc also B7+ Sincc two subtypes of Cw7 have been desenbed onc of which is less

ATLC 40 2 6 2E5 1B4 2F7 1D9 18 1E7 2C7 2C5 2C3 1C7 1E3 1B5 1Fb 1F2 2D11 2D9 1D3 1F3 NOTE Α •Reactivt CD CDS CD8 CDS CD8 CD4 CD4 CD4 CD4 CD4 CD4 C D 4 C D 4 C D 8 CDS C D 4 C D 4 C D 4 C D 4 C D 4 ATLCs were panet c.ells C M l yes yes yes yes yes yes yes yes yes yes yes yes y t s yes yes no no no no CD2 ( CD3 were def ned as

Redet vo 7 8 20 21 7 8 9 10 13 14 20 3 5 6 8 9 15 20 15 16 20 15 16 20 20 20 15 16 20 13 14 15 13 U 20 13 14 20 13 14 20 13 14 15 13 14 20 15 16 20 15 16 20 15 16 20 cells able to sia

Panel Cells· 2 0 16 20 21 16 20 16 20 Block ne MoAbsf HLA 1 not tested HLAI HLAI Broad HLAII DR Broad HLAII DR DR Broad HLAII Broad HLAII DR DO DQ DP DP Broad HLA Broad HLA Broad HLA ßroad HLA Broad HLA Broad HLA Brodd HLA I I 1 1 1

nificantlv tnaaer ATLC proliferatio a

Commoms anti Bw55 ant Cw3 anti Β18 anti Cw7 subtype anti DRw8 subtype anti DRw8 anti DRw8 anti DR private anti DR private ant! DQ blanfc anti DQ new anti DP inti DP anti HLA II anti HLA II anti HLA II anti HLA II anti HLA II anti HLA II d to be sianificantly Ivsed bv cytotoxic effector cells

tl n cytotoxicity blocking expenments the following anti HLA MAbs

(3)

INDUCTiON OF RECIPIENT ANTIDONOR RESPONSES

frequcntly i>ecn in HLA-B7 individuals K U is

possible lhat thc nonB7Cw7 subtype is recog n)7ed by clone 2F7 Cytotoxic activity of thc majonty of thc ATLCs tesled could be inhib-itcd by MoAbs direcied against HLA class Π struclures Similarly, concomitant analysis of data from panel and blockmg cxpcnmcnts led tn gcncral lo thc precise cluractcriAition of thc HLA class II specificily rccogm/cd by these ATLCs(Table2)

In this papcr, wc have mvestigatcd ihc rccogmlion rcperloirc üf 20 oi SS ATI Cs

dcrivcd from cclls lnliltraling a rejcctcd kid ncy Rcsults summ ιπ/cd in rable 2, indicatc

lhal cclls commi'ied againsl almost all Hl Λ spccihcitics mssmatchcd belwccn kidncy do

nor and rcupicnt (including Η L Α C and DP gencrally ignorcd m ciinical transplantation) couid bc cvidcnccd In this vicw, it should bc notcd thal graft invading cclls wcre dircttiy cloned after ibcir Isolation prior to any bulk culturc thus ruling out possible prefcrentiai in vitro cxpansion of ATLCs sensitizcd agamst a iew anfigcns Tbc f<iLt that lll ATLCs which wcre assumcd lo bc repräsentative of grill

invading celK, recogm/td HLA moleculcs cmpbast7cs tbe rolt of Hl Α rccognition in Ihc

rcjcclion process Howcvcr wecannot cxcludc Ihc possibility thal cclls not rccruitcd in thc donjng procedure using donor BLCL wcre commitlcd igainst non Hl Α molcculcs not borne by stimulatmg ceüs

REFERENCES

I M o r t d u J I Bonntvillt, Μ P c y n l M A cl il J C tm S Triebe ! f Misscnir d V C ünt> MC U il J (nvt.si 7« 874 I 9XC> Immunol 1 Ρ 1771 1484

6 t h t n Y x ' v a n s R l l > t ) ! l l (-k M s L l l ( t i u m

Immunol 102^1 1984

7 Austin Ρ Trowsdile I Rudd C α il Ν u u r e BirnsiibJc C I Bodmer Wl lirown U et il t e i l ^n ft] ]i)HS

2 C iroll PG DtWolf WC M L I U I C R et il T r i n pl inl Prot I 1 1809 1979

1 4 9 [9ΊΗ Η S i s i / u k i l Diussei I T o k u n a g i Κ cl il llislo

Referenties

GERELATEERDE DOCUMENTEN

th at causes serious d isease and h igh mortality rates in immunocomp romised p ersons, such as A ID S p atients and organ transp lant recip ients.. mostly nonclassical

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4294..

Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II

*Department of Medical Microbiology, Leiden University Medical Center, P.O.. mostly nonclassical locus products that exhibit limited polymorphism, HCMV could escape killing by

In contrast, soluble HLA-G1 remained stable throughout the chase (lower panel). In the presence of proteasome inhibitor, a deglycosylated degradation intermediate

Figure 3B shows that an extension of the cytoplasmic tail with– ACKV or – KV residues markedly reduced surface expression of these HLA-E mutants in US11

This pattern reflects dislocation to the cytosol and deglycosylation of MHC class I heavy chains, similar to what was shown earlier for endogenous MHC class I

The fact that we found an abrogation of US11- mediated dislocation, in the presence of proteasome inhibitor only and exclusively in cells lacking E2m-